Back
Moleculin Biotech 10K Form
Sell
29
MBRX
Moleculin Biotech
Last Price:
2.34
Seasonality Move:
-2.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MBRX News And Ratings
See the #1 stock for the next 7 days that we like better than MBRX
MBRX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-5.96M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.91 |
| Price / Book: | 0.39 |
Profitability
| EPS (TTM): | -11.81540 |
|---|---|
| Net Income (TTM): | $-25.17M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Moleculin Biotech Earnings Forecast
Key Moleculin Biotech Financial Ratios
- The Interest Expense is -1.02% of Operating Income.
- Per Share Earnings over the last 8 years have been positive in 5 years.
Moleculin Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MBRX |
| CUSIP: | 60855D |
| Website: | moleculin.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MBRX Technical Analysis vs Fundamental Analysis
Sell
29
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy or a Sell?
-
Moleculin Biotech stock is rated a Sell
The current Moleculin Biotech [MBRX] share price is $2.44. The Score for MBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.